FREDERICK, MD, USA I May 30, 2025 I Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company ...

Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

Zivanov, assistant professor of electrical and computer engineering, has received a prestigious Faculty Early Career ...

An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.